[go: up one dir, main page]

NO980566D0 - Allergen-XCD32 fusion proteins - Google Patents

Allergen-XCD32 fusion proteins

Info

Publication number
NO980566D0
NO980566D0 NO980566A NO980566A NO980566D0 NO 980566 D0 NO980566 D0 NO 980566D0 NO 980566 A NO980566 A NO 980566A NO 980566 A NO980566 A NO 980566A NO 980566 D0 NO980566 D0 NO 980566D0
Authority
NO
Norway
Prior art keywords
xcd32
allergen
fusion proteins
fusion
proteins
Prior art date
Application number
NO980566A
Other languages
Norwegian (no)
Other versions
NO980566L (en
Inventor
Geert C Mudde
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO980566L publication Critical patent/NO980566L/en
Publication of NO980566D0 publication Critical patent/NO980566D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO980566A 1995-08-16 1998-02-10 Allergen-XCD32 fusion proteins NO980566D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516760.7A GB9516760D0 (en) 1995-08-16 1995-08-16 Organic compounds
PCT/EP1996/003616 WO1997007218A1 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins

Publications (2)

Publication Number Publication Date
NO980566L NO980566L (en) 1998-02-10
NO980566D0 true NO980566D0 (en) 1998-02-10

Family

ID=10779307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980566A NO980566D0 (en) 1995-08-16 1998-02-10 Allergen-XCD32 fusion proteins

Country Status (16)

Country Link
EP (1) EP0846178A1 (en)
JP (1) JPH11513025A (en)
KR (1) KR19990036440A (en)
CN (1) CN1193353A (en)
AU (1) AU6873596A (en)
BR (1) BR9610239A (en)
CA (1) CA2227795A1 (en)
CZ (1) CZ43798A3 (en)
GB (1) GB9516760D0 (en)
HU (1) HUP9802349A3 (en)
IL (1) IL122898A0 (en)
NO (1) NO980566D0 (en)
PL (1) PL324897A1 (en)
SK (1) SK19398A3 (en)
TR (1) TR199800214T1 (en)
WO (1) WO1997007218A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
AU750358B2 (en) 1997-12-02 2002-07-18 Medarex, Inc. Cells expressing anti-Fc receptor binding components
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US8029803B2 (en) 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8025873B2 (en) 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8007805B2 (en) 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
BG65715B1 (en) * 2003-09-04 2009-08-31 Чавдар ВАСИЛЕВ Device for selective suppression of pathologic dna-specific b cells
BG65954B1 (en) * 2005-01-05 2010-07-30 Чавдар ВАСИЛЕВ Means for selective suppression of the activity of pathologic autoreactive b-cells
US9636415B2 (en) 2006-03-03 2017-05-02 S-Target Therapeutics Gmbh Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
EP1829895A1 (en) * 2006-03-03 2007-09-05 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
RS61098B1 (en) 2012-06-15 2020-12-31 Immunomic Therapeutics Inc Nucleic acids for treatment of allergies
CN109806388B (en) 2012-07-13 2022-03-08 S-目标疗法有限公司 Immunomodulatory vaccines
AU2013340899B2 (en) * 2012-11-01 2017-10-05 Veterinaerinstituttet New fusion proteins for the treatment of allergic diseases
US9005630B2 (en) 2012-11-01 2015-04-14 Veterinaerinstituttet Fusion proteins for the treatment of allergic diseases
HUE037252T2 (en) 2013-05-21 2018-08-28 Tyg Oncology Ltd Gastrin peptide immunogenic composition
CN113186167B (en) * 2021-04-28 2021-11-30 中国食品药品检定研究院 Method for determining biological activity of anti-CD 20 monoclonal antibody drug ADCP

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
AU2670995A (en) * 1994-05-26 1995-12-21 Innogenetics N.V. New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness

Also Published As

Publication number Publication date
KR19990036440A (en) 1999-05-25
EP0846178A1 (en) 1998-06-10
CZ43798A3 (en) 1998-06-17
NO980566L (en) 1998-02-10
MX9801253A (en) 1998-05-31
PL324897A1 (en) 1998-06-22
SK19398A3 (en) 1998-09-09
AU6873596A (en) 1997-03-12
CN1193353A (en) 1998-09-16
HUP9802349A2 (en) 1999-01-28
GB9516760D0 (en) 1995-10-18
WO1997007218A1 (en) 1997-02-27
CA2227795A1 (en) 1997-02-27
HUP9802349A3 (en) 1999-04-28
JPH11513025A (en) 1999-11-09
IL122898A0 (en) 1998-08-16
BR9610239A (en) 1999-06-15
TR199800214T1 (en) 1998-06-22

Similar Documents

Publication Publication Date Title
FI973162A0 (en) Anti-obesity proteins
FI971479L (en) Fused pyrrolocarbazoles
DK0807198T3 (en) joint system
DE69625368D1 (en) SWEAT-RESISTANT DEODORATING PREPARATIONS
FI953705A7 (en) Improved protein folding method
FI960073L (en) Protein separation
DE69839603D1 (en) ORNAMENTAL PROTEINS
DE69621211D1 (en) joint arrangement
FI961350L (en) Hapten-tagged peptides
FI954648A7 (en) Protein separation
FI952574A7 (en) Glycosyltransferase-active proteins
NO976058L (en) Recombinant Mistakine
DK0825860T3 (en) Prepare
NO980566D0 (en) Allergen-XCD32 fusion proteins
DK132892D0 (en) PROTEINS
FI970168L (en) Peptides
BR9609671A (en) Amino uracilas substituted
FI964363L (en) Peptides
FI972763A7 (en) Mutant proteins
DE69607261D1 (en) Connecting bridge
TR199701666A3 (en) Proteins
DE69625037D1 (en) SCRAP FUSION
BR9606756A (en) Peptide
FR2733287B1 (en) HOMOCINETIC JOINT
NO981052D0 (en) peptide